How to run an effective and efficient dermato‐oncology unit: a Dutch approach

The worldwide incidence of skin cancer (especially non‐melanoma skin cancer) has risen dramatically over the last decades. Skin cancer, including pre‐malignant lesions, is becoming a chronic disease. Adjustments in skin cancer health care need to be made. A disease management system for skin cancer is mandatory in order to avoid waiting lists and insure adequate treatment quality with ever growing numbers of patients requiring treatment. At the Catharina Hospital Eindhoven adjustments are being made on several levels of the dermato‐oncology unit in collaboration with Eindhoven University of Technology. The model combines technological improvements, training health care workers, training of general practitioners and prevention of skin cancer. We discuss our ideas and clinical experiences with managing a dermato‐oncology unit.

[1]  R. Stern,et al.  Risk of developing a subsequent nonmelanoma skin cancer in patients with a history of nonmelanoma skin cancer: a critical review of the literature and meta-analysis. , 2000, Archives of dermatology.

[2]  D. Moreno-Ramírez,et al.  Store-and-forward teledermatology in skin cancer triage: experience and evaluation of 2009 teleconsultations. , 2007, Archives of dermatology.

[3]  R. Clark,et al.  Microscopically Controlled Surgical Excision Combined with Ultrapulse CO2 Vaporization in the Management of a Patient with the Nevoid Basal Cell Carcinoma Syndrome , 1998, The Journal of dermatology.

[4]  Manfred Reichert,et al.  IT support for healthcare processes - premises, challenges, perspectives , 2007, Data Knowl. Eng..

[5]  Christine D. Brown,et al.  Specialty Clinics for the Dermatologic Care of Solid‐Organ Transplant Recipients , 2004, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[6]  G. Gupta,et al.  Prospective observational comparative study assessing the role of store and forward teledermatology triage in skin cancer , 2008, Clinical and experimental dermatology.

[7]  G. L. Collins,et al.  Changing demographics and pathology of nonmelanoma skin cancer in the last 30 years. , 2003, Seminars in cutaneous medicine and surgery.

[8]  F. D. de Gruijl,et al.  Predictions of skin cancer incidence in the Netherlands up to 2015 , 2005, The British journal of dermatology.

[9]  Jonathan M. Teich,et al.  Application of Information Technology: Automating Complex Guidelines for Chronic Disease: Lessons Learned , 2003, J. Am. Medical Informatics Assoc..

[10]  Carmen D Dirksen,et al.  Surgical excision vs Mohs' micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial , 2004, The Lancet.

[11]  A. Kopf,et al.  Lifetime risk for development of skin cancer in the U.S. population: current estimate is now 1 in 5. , 1996, Journal of the American Academy of Dermatology.

[12]  C. Proby,et al.  Specialist dermatology clinics for organ transplant recipients significantly improve compliance with photoprotection and levels of skin cancer awareness , 2006, The British journal of dermatology.

[13]  H. Comber,et al.  A population‐based study of skin cancer incidence and prevalence in renal transplant recipients , 2006, The British journal of dermatology.

[14]  C. Taylor,et al.  Evaluation of a nurse-care management system to improve outcomes in patients with complicated diabetes. , 2003, Diabetes care.

[15]  E. Devries,et al.  [Trends, causes, approach and consequences related to the skin-cancer epidemic in the Netherlands and Europe]. , 2006 .

[16]  C. Dirksen,et al.  Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-up. , 2008, The Lancet. Oncology.

[17]  K. E. Baker.  Will a physician assistant improve your dermatology practice? , 2000, Seminars in cutaneous medicine and surgery.

[18]  M. Nestor.  Dermatology practice management enhancement: implications for dermatology in the age of managed care. , 2000, Seminars in cutaneous medicine and surgery.

[19]  D. Nicol,et al.  Incidence and prediction of nonmelanoma skin cancer post-renal transplantation: a prospective study in Queensland, Australia. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[20]  J. Lear,et al.  Cutaneous basal cell carcinomas , 2001, Cancer.

[21]  Steven R Feldman,et al.  Skin cancer is among the most costly of all cancers to treat for the Medicare population. , 2003, Journal of the American Academy of Dermatology.

[23]  T. Tsuji,et al.  Cryosurgery and Topical Fluorouracil: A Treatment Method for Widespread Basal Cell Epithelioma in Basal Cell Nevus Syndrome , 1993, The Journal of dermatology.

[24]  M. Karagas,et al.  Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA , 1999, International journal of cancer.

[25]  S. van der Geer,et al.  Treatment of basal cell carcinomas in patients with nevoid basal cell carcinoma syndrome , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

[26]  D. Kuijpers,et al.  Photodynamic therapy as adjuvant treatment of extensive basal cell carcinoma treated with Mohs micrographic surgery. , 2004, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[27]  P. G. Lang,et al.  Long-term management of basal cell nevus syndrome with topical tretinoin and 5-fluorouracil. , 1992, Journal of the American Academy of Dermatology.

[28]  S. van der Geer,et al.  Treatment of the Patient with Nevoid Basal Cell Carcinoma Syndrome in a Megasession , 2009, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[29]  M Fieschi,et al.  Medical Decision Support Systems: Old Dilemmas and new Paradigms? , 2003, Methods of Information in Medicine.

[30]  D. Kuijpers,et al.  Local immune modulator (imiquimod 5% cream) as adjuvant treatment after incomplete Mohs micrographic surgery for large, mixed type basal cell carcinoma: a report of 3 cases. , 2006, Journal of drugs in dermatology : JDD.